These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 27896550)
21. HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019. Stengaard AR; Combs L; Supervie V; Croxford S; Desai S; Sullivan AK; Jakobsen SF; Santos Q; Simões D; Casabona J; Lazarus JV; de Wit JBF; Amort FM; Pharris A; Nerlander L; Raben D Euro Surveill; 2021 Nov; 26(47):. PubMed ID: 34823636 [TBL] [Abstract][Full Text] [Related]
22. Trends in HIV testing, prevalence among first-time testers, and incidence in most-at-risk populations in Spain: the EPI-VIH Study, 2000 to 2009. Diez M; Bleda MJ; Varela JR; Ordonana J; Azpiri MA; Vall M; Santos C; Viloria L; de Armas C; Urena JM; Trullen J; Pueyo I; Martinez B; Puerta T; Vera M; Sanz I; Junquera ML; Landa MC; Martinez E; Camara MM; Belda J; Bru FJ; Diaz A; Euro Surveill; 2014 Nov; 19(47):20971. PubMed ID: 25443036 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017). Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072 [TBL] [Abstract][Full Text] [Related]
24. Setting the scene, setting the targets. The Joint United Nations Programme on HIV/AIDS prevention targets of 2016 and estimating global pre-exposure prophylaxis targets. Coleman R Sex Health; 2018 Nov; 15(6):485-488. PubMed ID: 30496717 [TBL] [Abstract][Full Text] [Related]
25. A comprehensive review of available epidemiologic and HIV service data for female sex workers, men who have sex with men, and people who inject drugs in select West and Central African countries. MacAllister J; Sherwood J; Galjour J; Robbins S; Zhao J; Dam K; Grosso A; Baral SD J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2():S83-90. PubMed ID: 25723995 [TBL] [Abstract][Full Text] [Related]
26. Status of the HIV epidemic in key populations in the Middle East and north Africa: knowns and unknowns. Mumtaz GR; Chemaitelly H; AlMukdad S; Osman A; Fahme S; Rizk NA; El Feki S; Abu-Raddad LJ Lancet HIV; 2022 Jul; 9(7):e506-e516. PubMed ID: 35777412 [TBL] [Abstract][Full Text] [Related]
27. Engagement in the HIV Care Continuum among Key Populations in Tijuana, Mexico. Smith LR; Patterson TL; Magis-Rodriguez C; Ojeda VD; Burgos JL; Rojas SA; Zúñiga ML; Strathdee SA AIDS Behav; 2016 May; 20(5):1017-25. PubMed ID: 26354518 [TBL] [Abstract][Full Text] [Related]
28. HIV/AIDS epidemiology and prevention in China. Sheng L; Cao WK Chin Med J (Engl); 2008 Jul; 121(13):1230-6. PubMed ID: 18710645 [TBL] [Abstract][Full Text] [Related]
29. The changing face of HIV in Latin America and the Caribbean. García PJ; Bayer A; Cárcamo CP Curr HIV/AIDS Rep; 2014 Jun; 11(2):146-57. PubMed ID: 24824881 [TBL] [Abstract][Full Text] [Related]
30. Countries where HIV is concentrated among most-at-risk populations get disproportionally lower funding from PEPFAR. Grosso AL; Tram KH; Ryan O; Baral S Health Aff (Millwood); 2012 Jul; 31(7):1519-28. PubMed ID: 22778341 [TBL] [Abstract][Full Text] [Related]
31. A social systems analysis of implementation of El Salvador's national HIV combination prevention: a research agenda for evaluating Global Health Initiatives. Dickson-Gomez J; Glasman LA; Bodnar G; Murphy M BMC Health Serv Res; 2018 Nov; 18(1):848. PubMed ID: 30419904 [TBL] [Abstract][Full Text] [Related]
32. Epidemiology of HIV in Iran. Najafi Z; Taj L; Dadras O; Ghadimi F; Moradmand B; SeyedAlinaghi S Curr HIV Res; 2020; 18(4):228-236. PubMed ID: 32503409 [TBL] [Abstract][Full Text] [Related]
33. Adequate funding of comprehensive community-based programs for key populations needed now more than ever to reach and sustain HIV targets. DiCarlo MC; Dallabetta GA; Akolo C; Bautista-Arredondo S; Digolo HV; Fonner VA; Kumwenda GJ; Mbulaje P; Mwangi PW; Persuad NE; Sikwese S; Wheeler TA; Wolf RC; Mahler HR J Int AIDS Soc; 2022 Jul; 25(7):e25967. PubMed ID: 35880969 [TBL] [Abstract][Full Text] [Related]
34. National HIV Care Continua for Key Populations. Gupta S; Granich R J Int Assoc Provid AIDS Care; 2017; 16(2):125-132. PubMed ID: 28090799 [TBL] [Abstract][Full Text] [Related]
35. A decade of investments in monitoring the HIV epidemic: how far have we come? A descriptive analysis. Alfven T; McDougal L; Frescura L; Aran C; Amler P; Gill W Health Res Policy Syst; 2014 Oct; 12():62. PubMed ID: 25322764 [TBL] [Abstract][Full Text] [Related]
36. Development of a global index measuring national policy commitments to HIV prevention and treatment among people who inject drugs. Sevigny EL; Meylakhs P; Feizollahi MJ; Amini MR Int J Drug Policy; 2020 Oct; 84():102877. PubMed ID: 32717705 [TBL] [Abstract][Full Text] [Related]
37. The changing trends of HIV-1 prevalence and incidence from sentinel surveillance of five sub-populations in Yunnan, China, 2001-2010. Yang L; Chen M; Ma Y; Luo H; Yang C; Su Y; Chen H; Shi Y; Mei J; Jia M; Lu L BMC Public Health; 2015 Apr; 15():376. PubMed ID: 25886791 [TBL] [Abstract][Full Text] [Related]
38. Are we on course for reporting on the Millennium Development Goals in 2015? Rugg D; Marais H; Carael M; De Lay P; Warner-Smith M J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S69-76. PubMed ID: 19901629 [TBL] [Abstract][Full Text] [Related]
39. Mobile Health App for Self-Learning on HIV Prevention Knowledge and Services Among a Young Indonesian Key Population: Cohort Study. Garg PR; Uppal L; Mehra S; Mehra D JMIR Mhealth Uhealth; 2020 Sep; 8(9):e17646. PubMed ID: 32896831 [TBL] [Abstract][Full Text] [Related]
40. UN political declaration on HIV and AIDS: where to begin? Poku NK Lancet; 2016 Aug; 388(10046):743-4. PubMed ID: 27560262 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]